3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
fludarabine phosphate
10
Cyclophosphamide
8
Busulfan
8
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Antilymphocyte Serum
7
Tacrolimus
6
Methotrexate
5
Cyclosporine
5
thymoglobulin
4
Melphalan
4
Rituximab
3
Radiotherapy
3
Etoposide
3
Cord Blood Stem Cell Transplantation
3
Sirolimus
2
Ondansetron
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Carmustine
2
Calcium Dobesilate
2
Aprepitant
2
ruxolitinib
1
fludarabine
1
fedratinib
1
etoposide phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Neutrophilic, Chronic
×
tipifarnib
×
Clear all
No trials found.